Judy D. Olian - 24 Jul 2025 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
24 Jul 2025
Net transactions value
$0
Form type
4
Filing time
28 Jul 2025, 06:26:40 UTC
Previous filing
30 May 2025
Next filing
04 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Olian Judy D. Director C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING /s/ John S. Hess, Jr. under Power of Attorney 25 Jul 2025 0001605729

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $0 +1,190 +21% $0.000000 6,845 25 Jul 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Restricted Stock Unit Options Exercise $0 -1,190 -100% $0.000000 0 25 Jul 2025 Common Stock 1,190 $0.000000 Direct F1, F2, F3
transaction UTHR Restricted Stock Unit Award $0 +1,310 $0.000000 1,310 24 Jul 2025 Common Stock 1,310 $0.000000 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F2 Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock.
F3 Not applicable as restricted stock units do not have an expiration date.
F4 Annual non-employee director award.